Claraphi Advisory Network, LLC Seres Therapeutics, Inc. Transaction History

Claraphi Advisory Network, LLC

  • $248 Million
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019
SELL
$2.29 - $4.16 $58,724 - $106,679
-25,644 Closed
0 $0
Q2 2019

Jul 29, 2019
BUY
$2.28 - $7.35 $58,468 - $188,483
25,644 New
25,644 $83,000

Others Institutions Holding MCRB

# of Institutions
5
Shares Held
1.79M
Call Options Held
0
Put Options Held
0
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $1.71B
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email